iBio (IBIO) Capital Expenditures (2012 - 2026)
iBio (IBIO) posted Capital Expenditures of $19,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with $1,000 a year earlier and up 72.7% from the prior quarter.
Powered by 
Analysis
iBio (IBIO) Capital Expenditures (2012 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), iBio's Capital Expenditures came in at $578,000.
- Annual Capital Expenditures shows a five-year compound annual growth rate of -34.8% (FY2021 to FY2026).
- In prior fiscal years, iBio's Capital Expenditures was $16,000 in FY2025 (-92.4%), $210,000 in FY2024 (-96.3%), $5.74 million in FY2023 (-21.7%) and $7.33 million in FY2022 (+49.0%).
- Quarterly Capital Expenditures has run from a low of -$201,000 in fiscal Q3 2023 to a high of $3.43 million in fiscal Q4 2022 over five years.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was fiscal Q1 2022, with growth of 168.0%; the weakest was fiscal Q4 2025, with a decline of 99.5%.
- According to Business Quant data, Capital Expenditures for the three prior fiscal quarters was $11,000 (Q3 2026), $516,000 (Q2 2026) and $32,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.22 Bn | 1,098.80 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 614.95 Bn | 533.47 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 505.05 Bn | 478.16 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 368.08 Bn | 322.46 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.32 Bn | 262.31 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.58 Bn | 235.26 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 236.05 Bn | 191.45 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 190.61 Bn | 164.80 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 169.86 Bn | 116.50 Bn | 10.94 Bn | 533.00 Mn |
| 10 | iBio | 88.65 Mn | -176.56 Mn | - | 19,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,000.00 |
| Mar 31, 2026 | 11,000.00 |
| Dec 31, 2025 | 516,000.00 |
| Sep 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 1,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Jun 30, 2024 | 210,000.00 |
| Jun 30, 2023 | 506,000.00 |
| Mar 31, 2023 | -201,000.00 |
| Dec 31, 2022 | 2.95 Mn |
| Sep 30, 2022 | 2.48 Mn |
| Jun 30, 2022 | 3.43 Mn |
| Mar 31, 2022 | 644,000.00 |
| Dec 31, 2021 | 2.13 Mn |
| Sep 30, 2021 | 1.12 Mn |
| Jun 30, 2021 | 2.51 Mn |
| Mar 31, 2021 | 993,000.00 |
| Dec 31, 2020 | 994,000.00 |
| Sep 30, 2020 | 419,000.00 |
API Access
iBio Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "IBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=IBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();